Automation index
How much of a Pharmacovigilance officer’s job can AI already do?
An ADR case comes earlier. Calling it serious without staying quiet to the regulator do not.
This percentage does not predict how many people will lose their jobs.
Task comparison
IS WORK OVER?
Pharmacovigilance officer
27%
AI can already do 27% of this job.
#189 / 663
View rankingPharmacovigilance officer
Where the time goes
Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.
The time saving for each task is estimated separately.
| Task | Share | AI | Points |
|---|---|---|---|
Case, the file and MedDRA.EstimateNo public source provides a precise figure. This is our estimate. | 18% | 48% | +8.6 |
Seriousness, the link and the one that does not fit.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 40% | +6.4 |
File, the AEMPS deadline and not delaying.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 22% | +3.5 |
Signal, the aggregate and not playing it down.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 28% | +4.5 |
The doctor, the ADR and not arguing the story.EstimateNo public source provides a precise figure. This is our estimate. | 18% | 14% | +2.5 |
If it is serious, call it. And not staying quiet.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 12% | +1.9 |
| Total | 100% | 27% |
Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low
Skills and activities
- ADR
- MedDRA
- AEMPS
- safety signals
- seriousness
- causality
- case files
- regulatory deadlines
Sources for this job· O*NET 29-1051.00· ESCO/ISCO 2262
IS WORK OVER?
Nuclear medicine technologist
19%
#568 / 663
View rankingNuclear medicine technologist
Where the time goes
Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.
The time saving for each task is estimated separately.
| Task | Share | AI | Points |
|---|---|---|---|
Dose, calibrate and the patient.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 32% | +5.1 |
Inject, the vein and the one who moves.EstimateNo public source provides a precise figure. This is our estimate. | 22% | 8% | +1.8 |
Acquisition, the SPECT and the artefact.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 22% | +3.5 |
Protection, the area and not contaminating.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 28% | +4.5 |
The nuclear physician, the image and not repeating extra.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 18% | +2.9 |
Inject, and not contaminating the rest.EstimateNo public source provides a precise figure. This is our estimate. | 14% | 12% | +1.7 |
| Total | 100% | 19% |
Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low
Skills and activities
- isotopes
- calibrate doses
- SPECT
- radiopharmaceutical injection
- radiation protection
- contamination
- acquisition
- artefacts
Sources for this job· O*NET 29-2033.00· ESCO/ISCO 3211